Manhattan Scientifics' Technology Able To Detect Breast Cancer Three Years Earlier Th
 

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine. When fully developed and commercialized, Dr...

More...